Clinical Trial and Company Showcases
Clinical Trial and Company Showcase presentations are 15-minute promotional presentations that provide an overview of the company’s services, pipeline products, clinical trials, or mission-based initiatives for a company, non-profit organization, or contract/clinical research organization. Sessions are non-CME and solely promotional in nature.
Charting Proteomic Landscapes of Relapse and Resistance in Hematological Malignancies
Sponsored by Pixelgen Technologies
Saturday, December 6, 2025, 3:30 p.m. - 3:45 p.m.
OCCC - W208AB
For in-person participants only
Speaker:
Simon Fredriksson
Pixelgen Technologies
Evaluating Osivelotor in Sickle Cell Disease: Pivotal Trial Updates
Sponsored by Pfizer
Saturday, December 6, 2025, 1:30 p.m. - 1:45 p.m.
OCCC - W209AB
For in-person participants only
Speaker:
Geoffrey Allen, MD
Fast, Fresh, Fit: Unlocking the Potential of Cell Therapy through a Transformative, Scalable, and Accessible Approach to Impact More Patients Globally
Sponsored by Galapagos
Saturday, December 6, 2025, 1:30 p.m. - 1:45 p.m.
OCCC - W208AB
For in-person participants only
Speaker:
Omotayo Fasan, MD
Galapagos
Innovative Transplant Strategies: Omidubicel Interim Phase II Results in Severe Aplastic Anemia
Sponsored by Gamida Cell
Monday, December 8, 2025, 10:00 a.m. - 10:15 a.m.
OCCC - W209C
For in-person participants only
Speaker:
Ronit Simantov, MD
Gamida Cell
LIBRA – SCD : A Group Sequential Phase 2/3 Study Assessing Efficacy, and Safety of Rilzabrutinib in Participants with Sickle-Cell Disease (SCD)
Sponsored by Sanofi
Sunday, December 7, 2025, 4:00 p.m. - 4:15 p.m.
OCCC - W208AB
For in-person participants only
Speaker:
Ahmed Daak
LUMINA 3 – wAIHA : A Phase 3, Two Arm Study, Assessing Efficacy, and Safety of Rilzabrutinib in Participants with Warm Autoimmune Hemolytic Anemia (wAIHA)
Sponsored by Sanofi
Sunday, December 7, 2025, 4:15 p.m. - 4:30 p.m.
OCCC - W208AB
For in-person participants only
Speaker:
Ahmed Daak
The ALPHA3 Trial: Improving Outcomes Through the Combination of Next-gen CAR T and Advanced MRD Testing in LBCL
Sponsored by Foresight Diagnostics
Saturday, December 6, 2025, 3:30 p.m. - 3:45 p.m.
OCCC - W209C
For in-person participants only
Speaker:
David Kurtz, MD, PhD
Foresight Diagnostics
67th ASH Annual Meeting and exposition
Registration for ASH members, non-members, groups, exhibitors, and media is now open!